Nisa Investment Advisors’s Biogen BIIB Stock Holding History

Nisa Investment Advisors’s Portfolio BIIB Stock Details BIIB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$6.57M	Sell	35,820 -2,615	-7%	-$482K	0.02%	343
2025 Q4	$6.76M	Sell	38,435 -9,121	-19%	-$1.49M	0.02%	339
2025 Q3	$6.66M	Sell	47,556 -3,346	-7%	-$452K	0.03%	343
2025 Q2	$6.39M	Sell	50,902 -102,315	-67%	-$12.7M	0.03%	355
2025 Q1	$21M	Sell	153,217 -46,037	-23%	-$6.58M	0.1%	164
2024 Q4	$30.5M	Buy	199,254 +149,461	+300%	+$25.2M	0.12%	136
2024 Q3	$9.65M	Sell	49,793 -6,735	-12%	-$1.41M	0.06%	292
2024 Q2	$13.1M	Buy	56,528 +1,820	+3%	+$396K	0.08%	227
2024 Q1	$11.8M	Sell	54,708 -1,013	-2%	-$237K	0.08%	243
2023 Q4	$14.4M	Sell	55,721 -2,815	-5%	-$691K	0.1%	208
2023 Q3	$15M	Sell	58,536 -8,853	-13%	-$2.37M	0.11%	197
2023 Q2	$19.2M	Sell	67,389 -4,342	-6%	-$1.29M	0.14%	163
2023 Q1	$19.9M	Buy	71,731 +3,778	+6%	+$1.05M	0.16%	154
2022 Q4	$18.8M	Sell	67,953 -1,712	-2%	-$484K	0.15%	162
2022 Q3	$18.6M	Sell	69,665 -1,427	-2%	-$303K	0.16%	142
2022 Q2	$14.5M	Buy	71,092 +2,696	+4%	+$551K	0.13%	174
2022 Q1	$14.4M	Sell	68,396 -16,810	-20%	-$3.66M	0.1%	198
2021 Q4	$19.3M	Buy	85,206 +6,965	+9%	+$1.79M	0.14%	151
2021 Q3	$22.1K	Sell	78,241 -8,793	-10%	-$2.88M	0.13%	142
2021 Q2	$30.1K	Buy	87,034 +15,380	+21%	+$4.66M	0.19%	107
2021 Q1	$20K	Sell	71,654 -17,570	-20%	-$4.74M	0.13%	153
2020 Q4	$21.8M	Sell	89,224 -8,123	-8%	-$2.1M	0.14%	162
2020 Q3	$27.6M	Buy	97,347 +12,057	+14%	+$3.36M	0.22%	102
2020 Q2	$22.8M	Sell	85,290 -702	-0.8%	-$211K	0.21%	107
2020 Q1	$27.2M	Buy	85,992 +1,292	+2%	+$392K	0.3%	76
2019 Q4	$25.1M	Sell	84,700 -6,021	-7%	-$1.67M	0.22%	105
2019 Q3	$21.1M	Buy	90,721 +7,963	+10%	+$1.85M	0.19%	119
2019 Q2	$19.4M	Sell	82,758 -7,146	-8%	-$1.65M	0.18%	116
2019 Q1	$21.3M	Sell	89,904 -3,476	-4%	-$1.09M	0.21%	106
2018 Q4	$28.1M	Sell	93,380 -450	-0.5%	-$144K	0.31%	73
2018 Q3	$33.1M	Buy	93,830 +11,443	+14%	+$3.94M	0.3%	72
2018 Q2	$23.9M	Sell	82,387 -4,706	-5%	-$1.32M	0.25%	91
2018 Q1	$24.1M	Sell	87,093 -1,850	-2%	-$574K	0.25%	88
2017 Q4	$28.3M	Buy	88,943 +650	+0.7%	+$209K	0.29%	80
2017 Q3	$27.6M	Buy	88,293 +14,940	+20%	+$4.42M	0.31%	70
2017 Q2	$19.6M	Sell	73,353 -9,500	-11%	-$2.51M	0.23%	102
2017 Q1	$22.7M	Sell	82,853 -1,798	-2%	-$508K	0.27%	80
2016 Q4	$24M	Sell	84,651 -1,327	-2%	-$393K	0.29%	70
2016 Q3	$26.9M	Buy	85,978 +10,130	+13%	+$3M	0.35%	58
2016 Q2	$18.3M	Sell	75,848 -1,220	-2%	-$322K	0.25%	90
2016 Q1	$20.1M	Sell	77,068 -2,200	-3%	-$581K	0.29%	76
2015 Q4	$24.3M	Sell	79,268 -2,500	-3%	-$718K	0.35%	64
2015 Q3	$23.9M	Sell	81,768 -5,850	-7%	-$1.93M	0.37%	61
2015 Q2	$35.4M	Sell	87,618 -3,700	-4%	-$1.48M	0.5%	40
2015 Q1	$38.6M	Buy	91,318 +1,200	+1%	+$473K	0.53%	37
2014 Q4	$30.6M	Sell	90,118 -7,220	-7%	-$2.34M	0.42%	51
2014 Q3	$32.2M	Buy	97,338 +2,000	+2%	+$659K	0.45%	49
2014 Q2	$30.1M	Sell	95,338 -300	-0.3%	-$90.3K	0.42%	53
2014 Q1	$29.3M	Buy	95,638 +17,550	+22%	+$5.57M	0.42%	54
2013 Q4	$21.8M	Sell	78,088 -300	-0.4%	-$77.6K	0.31%	69
2013 Q3	$18.9M	Sell	78,388 -229	-0.3%	-$51.3K	0.29%	76
2013 Q2	$16.9M	Buy	+78,617	New	+$16.8M	0.26%	80

Other funds holding BIIB

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Nisa Investment Advisors's BIIB Position: Q1 2026 in Review

Nisa Investment Advisors reduced its Biogen (BIIB) stake by 6.8% in Q1 2026, selling an estimated $482K and leaving 35,820 shares worth $6.57M. The position accounts for 0.02% of the portfolio, ranked #343.

Nisa Investment Advisors first reported a position in BIIB in Q2 2013 and has held it in 52 quarters since. The position peaked at $38.6M in Q1 2015. 1,008 funds tracked by Wall St. Rank hold BIIB as of Q1 2026.

Nisa Investment Advisors held 35,820 shares of Biogen worth $6.57M as of Q1 2026.
Nisa Investment Advisors sold 2,615 Biogen shares in Q1 2026, an estimated $482K.
Biogen made up 0.02% of Nisa Investment Advisors's portfolio in Q1 2026, its #343 holding.
Nisa Investment Advisors first reported a position in Biogen in Q2 2013 and has held it in 52 quarters since.
Nisa Investment Advisors's Biogen position peaked at $38.6M in Q1 2015.
1,008 funds tracked by Wall St. Rank held Biogen as of Q1 2026.

Based on Nisa Investment Advisors's 13F filing for Q1 2026, filed 30 Apr 2026.